These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 7456654)
1. [The role of thrombocytes and thrombocyte aggregation inhibitors in coronary disease]. Schlimmer P ZFA (Stuttgart); 1980 Sep; 56(26):1621-4. PubMed ID: 7456654 [No Abstract] [Full Text] [Related]
2. [Anticoagulants and thrombocyte aggregation inhibitors in or following myocardial infarct]. Rühle H Z Arztl Fortbild (Jena); 1985; 79(11):463-6. PubMed ID: 3901541 [No Abstract] [Full Text] [Related]
3. Antiplatelet therapy in coronary heart disease. Emerging strategies for the treatment and prevention of acute myocardial infarction. Becker RC Arch Pathol Lab Med; 1993 Jan; 117(1):89-96. PubMed ID: 8418769 [TBL] [Abstract][Full Text] [Related]
7. [Use of thrombocyte aggregation inhibitors in cardiology]. Schmidt BM; Wehling M Internist (Berl); 1997 Dec; 38(12):1242-5. PubMed ID: 9465333 [No Abstract] [Full Text] [Related]
8. The role of platelets and antiplatelet drugs in ischemic heart disease. Pope EJ J S C Med Assoc; 1981 Feb; 77(2):57-60. PubMed ID: 6937719 [No Abstract] [Full Text] [Related]
9. Current status of platelet inhibitor therapy in coronary artery disease. Harbold NB Coll Works Cardiopulm Dis; 1982 May; 23():1-3. PubMed ID: 7047065 [No Abstract] [Full Text] [Related]
10. [What is safe in antithrombotic therapy after acute myocardial infarct?]. Kirchhof B; van de Loo J Internist (Berl); 1982 Dec; 23(12):686-91. PubMed ID: 6819247 [No Abstract] [Full Text] [Related]
11. Platelet-suppressive therapy in cardiovascular disease. Mehta J; Roy L Cardiovasc Clin; 1984; 14(3):211-34. PubMed ID: 6722852 [No Abstract] [Full Text] [Related]
12. [Summary: Secondary prophylaxis following myocardial re-infarct. Anticoagulants or thrombocyte function inhibitors?]. Breddin K; Loeliger EA Internist (Berl); 1980 Jul; 21(7):399. PubMed ID: 7007281 [No Abstract] [Full Text] [Related]
13. [Blood rheological effects in ischemic heart disease treated with antianginal and thrombolytic agents]. Savenkov MP; Volov NA; Tebloev KI Kardiologiia; 1981 Aug; 21(8):63-9. PubMed ID: 7289386 [TBL] [Abstract][Full Text] [Related]
14. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders]. Thiele R Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068 [No Abstract] [Full Text] [Related]
15. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments against aggregation inhibitors]. Reuter HD Internist (Berl); 1980 Jul; 21(7):390-2. PubMed ID: 7007277 [No Abstract] [Full Text] [Related]
16. [Long-term antithrombotic treatment in coronary disease]. Hodara M; Samama M J Mal Vasc; 1983; 8(1):28-32. PubMed ID: 6405004 [TBL] [Abstract][Full Text] [Related]
17. [Summary: Aggregation inhibitors in the prophylaxis of myocardial infarct]. Walter E; Weber E; Reuter HD Internist (Berl); 1980 Jul; 21(7):393. PubMed ID: 7007278 [No Abstract] [Full Text] [Related]
18. [Pro and con: Aggregation inhibitors in the prophylaxis of myocardial infarct. Arguments in favor of aggregation inhibitors]. Walter E; Weber E Internist (Berl); 1980 Jul; 21(7):387-9. PubMed ID: 7007276 [No Abstract] [Full Text] [Related]
19. Is fibrinolysis critical for acute coronary syndromes? Kluft C; Andreotti F Ital Heart J; 2001 Sep; 2(9):639-40. PubMed ID: 11666088 [No Abstract] [Full Text] [Related]
20. [Thrombocyte function and the repair of myocardial infarct]. Kinoshenko EI; Aliavi AL; Vlasenko MA Vrach Delo; 1989 Jan; (1):27-9. PubMed ID: 2718437 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]